îæ€çŽ¢
îæ€çŽ¢
î
Monopar Therapeutics Inc
MNPRîãŠã©ãããªã¹ãã«è¿œå
67.470USD
+3.080+4.78%
çµå€Â 06/18, 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
451.99Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
åçäºæž¬
é貚: USD æŽæ°æå»: 2026-06-18Monopar Therapeutics Incã®çŸåšã®åçäºæž¬ã¹ã³ã¢ã¯8.31ã§ããã€ãªãã¯ãããžãŒ & å»çç 究æ¥çã§ã¯389瀟äž139äœã§ãã ç®æšæ ªäŸ¡ã®å¹³åã¯109.00ã§ãæé«ã¯130.00ãæäœã¯93.00ã§ãã
ã¢ããªã¹ãè©äŸ¡
13
人ã®ã¢ããªã¹ãäºæ³ã«åºã¥ã
è²·ã
çŸåšã®è©äŸ¡
112.615
ç®æšæ ªäŸ¡
+66.91%
äžæäœå°
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
åæ¥ä»ç€Ÿæ¯èŒ
560
åèš
5
äžå€®å€
6
å¹³å
äŒç€Ÿå
è©äŸ¡
ã¢ããªã¹ã
Monopar Therapeutics Inc
MNPR
13
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
財åäºæž¬
EPS
åç
çŽå©ç
EBIT
äºæž¬å€
å®çžŸå€
å 責äºé ïŒã¢ããªã¹ãã®ã¬ãŒãã£ã³ã°ããã³ç®æšæ ªäŸ¡ã¯ãæ å ±æäŸã®ã¿ãç®çãšããŠLSEG Data & AnalyticsãæäŸãããã®ã§ãããæè³å©èšãæ§æãããã®ã§ã¯ãããŸããã
ãããã質å
Monopar Therapeutics Inc ã®ç®æšæ ªäŸ¡ã¯ãããã§ãã?
îã¢ããªã¹ãã¯ãMonopar Therapeutics Inc ã®ç®æšæ ªäŸ¡ã USD 109.00 ãšäºæ³ããæé«äºæ³ã¯ USD 130.00ãæäœäºæ³ã¯ USD 93.00 ãšäºæ³ããŠããŸãã
Monopar Therapeutics IncMNPR ã®æè¿ã® 1 æ ªåœããã®å©çã¯ã©ããªã£ãŠããŸãã?
îåžå Žäºæ³ã¯ USD -0.46 ã§ããããMonopar Therapeutics IncMNPR ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -0.61 ã§ããã次ã®ååæã® EPS 㯠USD -0.63 ãšäºæ³ãããŸãã
Monopar Therapeutics Inc ã«å¯Ÿããã¢ããªã¹ãã®è©äŸ¡ã¯äœã§ãã?
î13 ã¢ããªã¹ãã«ãã Monopar Therapeutics Inc æ ªã®è©äŸ¡ã«åºã¥ããšãã»ãšãã©ã®ã¢ããªã¹ã㯠買ã ã®ãã¬ã³ããæ¯æããŠããŸããä»ã®ã¢ããªã¹ãã®æèŠãèæ
®ããçµæãæçµçã« Monopar Therapeutics Inc ã®æ ªäŸ¡ã¯ è²·ã ãšè©äŸ¡ãããŸããããã¯ååŒã«é¢ããã¢ããã€ã¹ã§ã¯ãªãããšã«æ³šæããŠãã ããããã¯ãç¬èªã®åæãè¡ãå¿
èŠããããŸãã
